Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: Relevance for cardiovascular outcomes

Nutrition, Metabolism and Cardiovascular Diseases - Tập 27 Số 3 - Trang 191-200 - 2017
GianLuca Colussi1, Cristiana Catena1, Marileda Novello1, Nicole Bertin1, Leonardo A. Sechi2
1Internal Medicine, Department of Experimental and Medical Sciences, University of Udine, Udine, Italy.
2Internal Medicine, Department of Experimental and Medical Sciences, University of Udine, Udine, Italy. Electronic address: [email protected].

Tóm tắt

Từ khóa


Tài liệu tham khảo

Davis, 2003, Achieving optimal essential fatty acid status in vegetarians: current knowledge and practical implications, Am J Clin Nutr, 78, 640S, 10.1093/ajcn/78.3.640S

Welch, 2010, Am J Clin Nutr, 92, 1040, 10.3945/ajcn.2010.29457

Yano, 2011, Regional differences in hypertensive cardiovascular remodeling between fishing and farming communities in Japan, Am J Hypertens, 24, 437, 10.1038/ajh.2010.263

Colussi, 2015, ω-3 polyunsaturated fatty acids effects on the cardiometabolic syndrome and their role in cardiovascular disease prevention: an update from the recent literature, Recent Pat Cardiovasc Drug Discov, 9, 78, 10.2174/1574890110666150724115111

López, 2004, Upregulation of endothelial nitric oxide synthase in rat aorta after ingestion of fish oil-rich diet, Am J Physiol Heart Circ Physiol, 287, H567, 10.1152/ajpheart.01145.2003

Raimondi, 2005, n-3 polyunsaturated fatty acids supplementation decreases asymmetric dimethyl arginine and arachidonate accumulation in aging spontaneously hypertensive rats, Eur J Nutr, 44, 327, 10.1007/s00394-004-0528-5

Wang, 2004, Fish oil increases antioxidant enzyme activities in macrophages and reduces atherosclerotic lesions in apoE-knockout mice, Cardiovasc Res, 61, 169, 10.1016/j.cardiores.2003.11.002

Chisaki, 2003, Eicosapentaenoic acid suppresses basal and insulin-stimulated endothelin-1 production in human endothelial cells, Hypertens Res, 26, 655, 10.1291/hypres.26.655

Christensen, 1997, n-3 fatty acids do not decrease plasma endothelin levels in healthy individuals, Scand J Clin Lab Invest, 57, 495, 10.3109/00365519709084599

Wu, 2014, Fish-oil supplementation alters numbers of circulating endothelial progenitor cells and microparticles independently of eNOS genotype, Am J Clin Nutr, 100, 1232, 10.3945/ajcn.114.088880

Hoshi, 2013, Omega-3 fatty acids lower blood pressure by directly activating large-conductance Ca2+-dependent K+ channels, Proc Natl Acad Sci U S A, 110, 4816, 10.1073/pnas.1221997110

Sukumar, 2012, Constitutively active TRPC channels of adipocytes confer a mechanism for sensing dietary fatty acids and regulating adiponectin, Circ Res, 111, 191, 10.1161/CIRCRESAHA.112.270751

Wu, 2013, Effect of fish oil on circulating adiponectin: a systematic review and meta-analysis of randomized controlled trials, J Clin Endocrinol Metab, 98, 2451, 10.1210/jc.2012-3899

Grenon, 2015, Short-term, high-dose fish oil supplementation increases the production of Omega-3 fatty acid-derived mediators in patients with peripheral artery disease (the OMEGA-PAD I trial), J Am Heart Assoc, 4, e002034, 10.1161/JAHA.115.002034

Din, 2013, Effect of ω-3 fatty acid supplementation on endothelial function, endogenous fibrinolysis and platelet activation in patients with a previous myocardial infarction: a randomised controlled trial, BMJ Open, 3, e003054, 10.1136/bmjopen-2013-003054

Din, 2013, Effect of ω-3 fatty acid supplementation on endothelial function, endogenous fibrinolysis and platelet activation in male cigarette smokers, Heart Br Card Soc, 99, 168

Siasos, 2013, Effects of Ω-3 fatty acids on endothelial function, arterial wall properties, inflammatory and fibrinolytic status in smokers: a cross over study, Int J Cardiol, 166, 340, 10.1016/j.ijcard.2011.10.081

Oh, 2014, Omega-3 fatty acid therapy dose-dependently and significantly decreased triglycerides and improved flow-mediated dilation, however, did not significantly improve insulin sensitivity in patients with hypertriglyceridemia, Int J Cardiol, 176, 696, 10.1016/j.ijcard.2014.07.075

Singhal, 2013, Docosahexaenoic acid supplementation, vascular function and risk factors for cardiovascular disease: a randomized controlled trial in young adults, J Am Heart Assoc Cardiovasc Cerebrovasc Dis, 2

Wang, 2012, Effect of omega-3 fatty acids supplementation on endothelial function: a meta-analysis of randomized controlled trials, Atherosclerosis, 221, 536, 10.1016/j.atherosclerosis.2012.01.006

Xin, 2012, Effect of fish oil supplementation on fasting vascular endothelial function in humans: a meta-analysis of randomized controlled trials, PLoS ONE, 7, e46028, 10.1371/journal.pone.0046028

Jump, 2002, The biochemistry of n-3 polyunsaturated fatty acids, J Biol Chem, 277, 8755, 10.1074/jbc.R100062200

Serhan, 2014, Pro-resolving lipid mediators are leads for resolution physiology, Nature, 510, 92, 10.1038/nature13479

Meydani, 1991, Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women, J Nutr, 121, 547, 10.1093/jn/121.4.547

Oh, 2010, GPR120 is an Omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects, Cell, 142, 687, 10.1016/j.cell.2010.07.041

Williams-Bey, 2014, Omega-3 free fatty acids suppress macrophage inflammasome activation by inhibiting NF-κB activation and enhancing autophagy, PloS One, 9, e97957, 10.1371/journal.pone.0097957

Colussi, 2014, Effects of the consumption of fish meals on the carotid Intima Media thickness in patients with hypertension: a prospective study, J Atheroscler Thromb, 21, 941, 10.5551/jat.22921

Skilton, 2012, Impaired fetal growth and arterial wall thickening: a randomized trial of Omega-3 supplementation, Pediatrics, 129, e698, 10.1542/peds.2011-2472

Thies, 2003, Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial, Lancet, 361, 477, 10.1016/S0140-6736(03)12468-3

Yamano, 2015, Impact of eicosapentaenoic acid treatment on the fibrous cap thickness in patients with coronary atherosclerotic plaque: an optical coherence tomography study, J Atheroscler Thromb, 22, 52, 10.5551/jat.25593

Wang, 2014, The ω-3 polyunsaturated fatty acid, eicosapentaenoic acid, attenuates abdominal aortic aneurysm development via suppression of tissue remodeling, PloS One, 9, e96286, 10.1371/journal.pone.0096286

Colussi, 2015, The metabolic syndrome and the membrane content of polyunsaturated fatty acids in hypertensive patients, Metab Syndr Relat Disord, 13, 343, 10.1089/met.2015.0025

Colussi, 2004, Omega-3 polyunsaturated fatty acids decrease plasma lipoprotein(a) levels in hypertensive subjects, Clin Nutr, 23, 1246, 10.1016/j.clnu.2004.08.001

Pase, 2011, Do long-chain n-3 fatty acids reduce arterial stiffness? A meta-analysis of randomised controlled trials, Br J Nutr, 106, 974, 10.1017/S0007114511002819

Tousoulis, 2014, Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome, Atherosclerosis, 232, 10, 10.1016/j.atherosclerosis.2013.10.014

Bryant, 2015, Higher oily fish consumption in late pregnancy is associated with reduced aortic stiffness in the child at Age 9 years, Circ Res, 116, 1202, 10.1161/CIRCRESAHA.116.305158

Colussi, 2015, The vascular response to vasodilators is related to the membrane content of polyunsaturated fatty acids in hypertensive patients, J Hypertens, 33, 993, 10.1097/HJH.0000000000000495

Bønaa, 1990, Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. A population-based intervention trial from the Tromsø study, N Engl J Med, 322, 795, 10.1056/NEJM199003223221202

Liu, 2011, Long-chain omega-3 fatty acids and blood pressure, Am J Hypertens, 24, 1121, 10.1038/ajh.2011.120

Park, 2010, Association between 24-hour ambulatory blood pressure and erythrocyte n-3 polyunsaturated fatty acids in Korean subjects with hypertension, Nutr Res, 30, 807, 10.1016/j.nutres.2010.09.013

Prisco, 1998, Effect of medium-term supplementation with a moderate dose of n-3 polyunsaturated fatty acids on blood pressure in mild hypertensive patients, Thromb Res, 91, 105, 10.1016/S0049-3848(98)00046-2

Mori, 1999, Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans, Hypertension, 34, 253, 10.1161/01.HYP.34.2.253

Russo, 1995, Omega-3 polyunsaturated fatty acid supplements and ambulatory blood pressure monitoring parameters in patients with mild essential hypertension, J Hypertens, 13, 1823, 10.1097/00004872-199512010-00059

Colussi, 2014, Fish meal supplementation and ambulatory blood pressure in patients with hypertension: relevance of baseline membrane fatty acid composition, Am J Hypertens, 27, 471, 10.1093/ajh/hpt231

Appel, 1993, Does supplementation of diet with “fish oil” reduce blood pressure? A meta-analysis of controlled clinical trials, Arch Intern Med, 153, 1429, 10.1001/archinte.1993.00410120017003

Morris, 1993, Does fish oil lower blood pressure? A meta-analysis of controlled trials, Circulation, 88, 523, 10.1161/01.CIR.88.2.523

Geleijnse, 2002, Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials, J Hypertens, 20, 1493, 10.1097/00004872-200208000-00010

Campbell, 2013, A systematic review of fish-oil supplements for the prevention and treatment of hypertension, Eur J Prev Cardiol, 20, 107, 10.1177/2047487312437056

Miller, 2014, Long-chain Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials, Am J Hypertens, 27, 885, 10.1093/ajh/hpu024

Yang, 2016, Fish, long-chain n-3 PUFA and incidence of elevated blood pressure: a meta-analysis of prospective cohort studies, Nutrients, 8, 58, 10.3390/nu8010058

Danaei, 2009, The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors, PLoS Med, 6, e1000058, 10.1371/journal.pmed.1000058

Bang, 1980, The composition of the Eskimo food in north western Greenland, Am J Clin Nutr, 33, 2657, 10.1093/ajcn/33.12.2657

Burr, 1989, Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART), Lancet, 2, 757, 10.1016/S0140-6736(89)90828-3

Dietary supplementation with n-3 polyunsaturated fatty acids, 1999, Vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico, Lancet, 354, 447

Burr, 2003, Lack of benefit of dietary advice to men with angina: results of a controlled trial, Eur J Clin Nutr, 57, 193, 10.1038/sj.ejcn.1601539

Ness, 2002, The long-term effect of dietary advice in men with coronary disease: follow-up of the Diet and Reinfarction trial (DART), Eur J Clin Nutr, 56, 512, 10.1038/sj.ejcn.1601342

Yokoyama, 2007, Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis, Lancet, 369, 1090, 10.1016/S0140-6736(07)60527-3

Greene, 2016, Effects of polyunsaturated fatty acid treatment on postdischarge outcomes after acute myocardial infarction, Am J Med, 117, 340

Investigators, 2008, Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial, Lancet, 372, 1223, 10.1016/S0140-6736(08)61239-8

Kromhout, 2010, n-3 fatty acids and cardiovascular events after myocardial infarction, N Engl J Med, 363, 2015, 10.1056/NEJMoa1003603

Rauch, 2010, OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction, Circulation, 122, 2152, 10.1161/CIRCULATIONAHA.110.948562

Galan, 2010, Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial, BMJ, 341, c6273, 10.1136/bmj.c6273

Trial Investigators, 2012, n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia, N Engl J Med, 367, 309, 10.1056/NEJMoa1203859

Risk and Prevention Study Collaborative Group, 2013, n-3 fatty acids in patients with multiple cardiovascular risk factors, N Engl J Med, 368, 1800, 10.1056/NEJMoa1205409

Writing Group for the AREDS2 Research Group, 2014, Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial, JAMA Intern Med, 174, 763, 10.1001/jamainternmed.2014.328

Wen, 2014, Effects of Omega-3 fatty acid on major cardiovascular events and mortality in patients with coronary heart disease: a meta-analysis of randomized controlled trials, Nutr Metab Cardiovasc Dis, 24, 470, 10.1016/j.numecd.2013.12.004

Zheng, 2014, The limited effect of omega-3 polyunsaturated fatty acids on cardiovascular risk in patients with impaired glucose metabolism: a meta-analysis, Clin Biochem, 47, 369, 10.1016/j.clinbiochem.2013.11.025

Chowdhury, 2014, Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis, Ann Intern Med, 160, 398, 10.7326/M13-1788

Chowdhury, 2012, Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis, BMJ, 345, e6698, 10.1136/bmj.e6698